Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

BACKGROUND: In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express differently between primary and metastatic tumor. Therefore, we aimed to compare the differential expressions of PD-1, PD-L1 and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Zhang, Xingming, Yin, Xiaoxue, Zhang, Haoran, Sun, Guangxi, Yang, Yaojing, Chen, Junru, Zhu, Xudong, Zhao, Peng, Zhao, Jinge, Liu, Jiandong, Chen, Ni, Wang, Jia, Shen, Pengfei, Zeng, Hao
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2019
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6469103/
https://ncbi.nlm.nih.gov/pubmed/30992011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5578-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars